Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06931795

Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA) - Adult

Implementation of a HABIT-ILE Intervention at the William Lennox Neurological Centre for Sub-acute Adult Post-stroke Patients (<6 Mois): a Randomised Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of patients with sub-acute post-stroke

Detailed description

The aim is to investigate, for the first time, the effectiveness of HABIT-ILE therapy in a hospital setting in the treatment of a population representative of the clinical population for adult patients with subacute stroke. The hypothesis is that an in-hospital HABIT-ILE protocol will be more effective than conventional therapies usually given to patients with sub-acute post-stroke, and that this difference will be objectively demonstrated by clinical assessments of motor function, cognition and participation conducted before and after treatment periods. The aim of the study is therefore to evaluate the effect of intensive bimanual hand-arm therapy including the lower extremities (HABIT-ILE) on body functions and structures, activity and participation in adulte patients suffering from subacute stroke..

Conditions

Interventions

TypeNameDescription
BEHAVIORALHABIT-ILE2 weeks HABIT-ILE
BEHAVIORALConventional intervention2 weeks usual intervention (waitlist group)

Timeline

Start date
2025-04-15
Primary completion
2026-12-20
Completion
2026-12-24
First posted
2025-04-17
Last updated
2025-04-17

Locations

3 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06931795. Inclusion in this directory is not an endorsement.